Reverse Transcriptase News and Research

RSS
New compounds for the treatment of HIV/AIDS

New compounds for the treatment of HIV/AIDS

Blips and AIDS therapy

Blips and AIDS therapy

New 3-DCR HIV strain does not respond to three classes of anti-retroviral medication

New 3-DCR HIV strain does not respond to three classes of anti-retroviral medication

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

Finding points towards the possibility of retrovirus involvement in ALS (amyotrophic lateral sclerosis)

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Genetic mutations and cellular modifications may provide clues to the associations between slight genetic abnormalities and often fatal diseases

Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria

Protease inhibitors used to treat HIV-1 infection may also be effective for treatment or prevention of malaria

Cellular enzyme represents a potential new target for developing improved HIV drugs

Cellular enzyme represents a potential new target for developing improved HIV drugs

One group of drugs that is effective in fighting HIV may also be promoting the death of sensory nerves in the skin

One group of drugs that is effective in fighting HIV may also be promoting the death of sensory nerves in the skin

Generic tritherapy can be used as a basic treatment for AIDS

Generic tritherapy can be used as a basic treatment for AIDS

FDA reinforces use of Sustiva in first-line HIV combination therapy

FDA reinforces use of Sustiva in first-line HIV combination therapy

First whole-genome survey of where three commonly used retroviruses into human DNA

First whole-genome survey of where three commonly used retroviruses into human DNA

Approval of fixed-dose combination treatments for HIV-1 infection

Approval of fixed-dose combination treatments for HIV-1 infection

FDA approves two fixed-dose combination treatments for HIV-1 infection

FDA approves two fixed-dose combination treatments for HIV-1 infection

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

Study shows safe, effective therapy for previously untreated patients with HIV & hepatitis C

Researchers discover a mechanism that blocks replication of a retrovirus

Researchers discover a mechanism that blocks replication of a retrovirus

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

Study evaluates effectiveness of LEXIVA/ritonavir and Lopinavir/ritonavir in protease inhibitor

Relatively difficult for the AIDS virus to develop resistance to the drug, tenofovir, or the DAPY (diarylpyrimidine) family of compounds

Relatively difficult for the AIDS virus to develop resistance to the drug, tenofovir, or the DAPY (diarylpyrimidine) family of compounds

Risk of artery plaques increased by use of HIV drugs

Risk of artery plaques increased by use of HIV drugs

IPM takes over Microbicide development to protect against sexual transmission of HIV

IPM takes over Microbicide development to protect against sexual transmission of HIV